• Issue

    Epilepsia Open: Volume 9, Issue 1

    1-456
    February 2024

ISSUE INFORMATION

Open Access

Issue Information

  • Pages: 1-10
  • First Published: 04 February 2024

EDITORIAL

Open Access

Thank you to our reviewers of 2023

  • Pages: 11-14
  • First Published: 23 January 2024

CRITICAL REVIEWS

Open Access

Phenotypic and genotypic characterization of NPRL3-related epilepsy: Two case reports and literature review

  • Pages: 33-40
  • First Published: 30 October 2023
Phenotypic and genotypic characterization of NPRL3-related epilepsy: Two case reports and literature review

This study expands the phenotypic and genotypic spectra of NPRL3-related epilepsy by reporting two cases with different novel variants. Following a review of the literature, it was observed that patients harboring various NPRL3 variants exhibited a variability of clinical manifestations. Also, patients carrying nonsense mutations are frequently prone to drug resistance and other severe comorbidities such as developmental delay, but more cases need to be collected to confirm these findings.

Open Access

Role of the glymphatic system and perivascular spaces as a potential biomarker for post-stroke epilepsy

  • Pages: 60-76
  • First Published: 02 December 2023
Role of the glymphatic system and perivascular spaces as a potential biomarker for post-stroke epilepsy

Stroke often leads to epilepsy and is one of the main causes of epilepsy in elderly patients, with no preventative treatment available. The brain's waste removal system, called the glymphatic system which consists of perivascular spaces, may be involved. Enlargement or asymmetry of perivascular spaces could play a role in this and can be visualized with advanced brain imaging after a stroke. Detecting enlarged perivascular spaces in stroke patients could help identify those at risk for post-stroke epilepsy.

ORIGINAL ARTICLES

Open Access

Leukotriene antagonists reduce epileptic seizures-related hospitalization in older adult populations with allergic rhinitis or asthma: A population-based cohort study using the Shizuoka Kokuho database: The Shizuoka study

  • Pages: 200-209
  • First Published: 25 October 2023
Leukotriene antagonists reduce epileptic seizures-related hospitalization in older adult populations with allergic rhinitis or asthma: A population-based cohort study using the Shizuoka Kokuho database: The Shizuoka study

This study examined if leukotriene receptor antagonists (LTRAs), commonly used for asthma or allergies, could lower seizure risk in older adults. Analyzing health records of 60-89 year olds with asthma or allergies, we found a reduced rate of seizure-related hospitalizations in those starting LTRAs, though this was not as evident in diabetic patients. Our results suggest the potential benefits of LTRAs in preventing seizures in older adults with respiratory issues, but further research is needed to confirm these findings.

Open Access

Fenfluramine increases survival and reduces markers of neurodegeneration in a mouse model of Dravet syndrome

  • Pages: 300-313
  • First Published: 28 November 2023

Dravet syndrome is a severe epilepsy disorder that impairs learning and causes premature death. Clinical studies in patients with Dravet syndrome show that fenfluramine reduces convulsive seizures. Additional studies suggest that fenfluramine may have benefits beyond seizures, including promoting survival and improving control over emotions and behavior. Our study is the first to use a Dravet mouse model to investigate nonseizure outcomes of fenfluramine. Results showed that fenfluramine treatment of Dravet mice reduced neuroinflammation significantly more than saline treatment. Fenfluramine-treated Dravet mice also lived longer than saline-treated mice. These results support clinical observations that fenfluramine may have benefits beyond seizures.

SHORT RESEARCH ARTICLES

ANNOUNCEMENT

Open Access

Epilepsia Open – February 2024 Announcements

  • Pages: 455-456
  • First Published: 04 February 2024